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of cancers, including those of the 
colon, breast, and prostate (Bostick et 
al., 1993; Garland et al., 1985, 1990; 
Hanchette and Schwartz, 1992; Kearney 
et al., 1996), is strong. However, sev-
eral large epidemiologic surveys have 
not demonstrated such a correlation 
with skin cancer (Hunter et al., 1992; 
van Dam et al., 2000; Weinstock et 
al., 1992). One potential complica-
tion is that UVB radiation has the dual 
effect of promoting vitamin D3  synthesis 
in the skin (which can be further con-
verted to 1,25(OH)2D3) and increasing 
DNA damage, leading to skin cancer. 
Thus, although UVR may be an effi-
cient means of providing the nutritional 
requirement for vitamin D, the advan-
tage to the skin may be countered by the 
increased risk of mutagenesis. However, 
recent studies indicate that the skin has 
evolved a vitamin D signaling mecha-
nism whereby the harmful effects of 
UVR may be mitigated.
The study by Ellison et al. (2008) 
in this issue demonstrates the protec-
tive role of VDR for UVR-induced skin 
tumors. Earlier studies indicated that 
mice null for VDR were highly sus-
ceptible to epidermal tumor formation 
induced by either the oral administra-
tion of the carcinogen 7,12-dimethyl-
benzanthracene (DMBA) (Zinser et al., 
2002) or its topical application (Indra 
et al., 2007). In the former study, the 
tumors were mostly papillomas, but 
several BCCs were observed. No SCCs 
were reported. In the latter study, only 
benign tumors were seen in the VDR 
null mice, unlike RXRα null mice, 
which developed both BCCs and SCCs 
(Indra et al., 2007). Ellison et al. (2008) 
confirmed the report by Zinser et al. 
(2002) demonstrating that oral admin-
istration of DMBA induced skin tumors 
in all of the VDR null mice and none of 
the wild-type mice. Furthermore, most 
of the tumors that formed appeared to 
originate from the folliculosebaceous 
unit. Importantly, Ellison et al. (2008) 
did not report increased susceptibil-
ity to DMBA-induced tumor forma-
tion in mice lacking the enzyme for 
1,25(OH)2D3 production (CYP27B1). 
The authors thus concluded that, at 
least for DMBA induction of tumors, 
VDR protection does not require its 
principal ligand, 1,25(OH)2D3.
SCCs (Danaee et al., 2006), and poly-
morphisms of the Ptch1 gene have 
altered the resistance to SCC formation 
in mice expressing an activated ras 
oncogene (Wakabayashi et al., 2007). 
Thus, alterations in the Hh signaling 
pathway contribute to the formation of 
both SCC and BCC.
1,25-Dihydroxyvitamin D3 (1,25 
(OH)2D3) has been evaluated for its 
potential anticancer activity for approx-
imately 25 years (Eisman et al., 1979). 
The list of malignant cells that express 
the receptor for 1,25(OH)2D3—vitamin 
D receptor (VDR)—is now quite 
extensive and for the purposes of this 
Commentary includes BCCs and SCCs 
(Kamradt et al., 2003; Ratnam et al., 
1996), as well as melanomas (Colston 
et al., 1981). The accepted basis for 
the promise of 1,25(OH)2D3 in the pre-
vention and treatment of malignancy 
includes its antiproliferative, prodif-
ferentiating effects on most cell types. 
Epidemiologic evidence supporting 
the importance of adequate vitamin 
D nutrition (including sunlight expo-
sure) for the prevention of a number 
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More than 1 million skin cancers occur annually in the United States—of 
which 80% are basal-cell carcinoma (BCC), 16% are squamous-cell carcinoma 
(SCC), and 4% are melanomas—making skin cancer by far the most common 
cancer (Greenlee et al., 2001). UVR is the major etiologic agent. UV wave-
lengths shorter than 280 nm (UVC) are absorbed by the ozone layer and do 
not reach the earth. UV wavelengths longer than 320 nm (UVA) have limited 
ability to induce the characteristic mutations in DNA seen in epidermal can-
cers. Thus, UVB, with a spectrum between 280 and 320 nm, is the major cause 
of these cancers (Freeman et al., 1989), but this is the same spectrum required 
for vitamin D production in the skin.  Is there a link?
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The principal genotoxic lesions 
induced by UVR are cyclobutane 
pyrimidine dimers and pyrimidine (6-4) 
pyrimidone photoproducts, which, if 
not repaired, result in C-to-T or CC-to-
TT mutations, the UVB “signature” 
lesion (Hussein, 2005). Mutations in 
p53 are common (50–90%) in both 
BCC and SCC (Brash et al., 1991; 
Daya-Grosjean and Sarasin, 2005; 
Ziegler et al., 1993, 1994), as well 
as in actinic keratoses, the precur-
sor lesions to SCC (Bito et al., 1995). 
Precursor lesions for BCC have not 
been identified, but BCCs are thought 
to arise from interfollicular basal cells, 
hair follicles, and sebaceous glands. 
Mutations in ras are much more com-
mon in SCC than in BCC (Reifenberger 
et al., 2005), whereas mutations in the 
hedgehog (Hh) signaling pathway—
in particular, in patched 1 (Ptch1)—
characterize BCC (Aszterbaum et 
al., 1998, 1999; Hahn et al., 1996; 
Johnson et al., 1996). However, loss 
of heterozygosity in the region includ-
ing the Ptch1 gene has been reported 
in a high percentage of both BCCs and 
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At this point the authors turned 
their attention to UVR-induced skin 
tumors comparing VDR null mice with 
wild-type controls. The mice were of 
C57BL/6 background, a strain rela-
tively resistant to UVR-induced skin 
tumors. Even at the very high doses of 
UVB used in these experiments, only 
4 of 23 wild-type mice developed 
tumors by 45 weeks after the start of 
UVR, 1 of which was classified as an 
SCC. In contrast, all 22 of the VDR null 
mice developed tumors, and 10 of the 
27 tumors analyzed were classified as 
SCC, although markers to document 
this classification were not provided. 
Taken at face value, therefore, it would 
appear that UVR-induced tumors in 
VDR null mice differ in type compared 
with DMBA-induced tumors, with SCC 
predominating following UVR and 
BCC and folliculosebaceous tumors 
predominating after DMBA.
Potential mechanisms were then 
explored. The skin of VDR null mice 
appeared to have greater cyclobutane 
pyrimidine dimer formation following 
UVR, suggesting a DNA repair defi-
ciency. Previous studies with cultured 
keratinocytes have demonstrated that 
1,25(OH)2D3 and analogs not thought 
to act via the nuclear configuration of 
the VDR were also protective against 
UVR-induced cyclobutane pyrimidine 
dimer formation (or accelerated their 
repair) (Dixon et al., 2005; Gupta et 
al., 2007). Ellison et al. (2008) did not 
test whether CYP27B1 null mice were 
also predisposed to UVR-induced 
tumor formation, so the results in their 
article are silent as to whether this is 
a 1,25(OH)2D3-independent action 
of VDR. Apoptosis following a single 
exposure to UVR was reduced in VDR 
null mice, although no differences 
between wild-type and null mice were 
shown for p53 induction by UVR. 
These observations are discordant 
with earlier observations (De Haes et 
al., 2003) that 1,25(OH)2D3 increases 
p53 levels and protects keratinocytes 
from UVR-induced apoptosis (Gupta 
et al., 2007), suggesting that VDR 
and 1,25(OH)2D3 might have oppo-
site effects in these responses to UVR. 
This possibility could be tested by 
comparing the responses in CYP27B1 
null mice to those in VDR null mice. 
The proliferative response to UVR 
was also slightly reduced in the VDR 
null epidermis, which, despite the 
decrease in apoptosis, seems to have 
resulted in a thinner epidermis in the 
VDR null compared with wild-type 
mice, although UVR induced epider-
mal thickening compared with the 
nonirradiated controls of either gen-
otype. This result is consistent with 
earlier studies (De Haes et al., 2003; 
Gupta et al., 2007) demonstrating that 
1,25(OH)2D3 enhances cell survival in 
keratinocytes after UVR, but it again 
raises the question of whether these 
are 1,25(OH)2D3-dependent or -inde-
pendent actions of VDR. The finding of 
the thinner epidermis in the VDR null 
mouse relative to controls is surpris-
ing, however, considering the higher 
proliferation rates in the epidermis 
and underlying folliculosebaceous 
unit of the VDR null mouse compared 
with controls under basal conditions 
(Bikle et al., 2006; Xie et al., 2002).
What, then, might be the underlying 
mechanisms? The DMBA studies pro-
ducing tumors primarily of folliculo-
sebaceous origin suggest that Hh 
signaling might be altered in VDR null 
skin. Appreciation of the pivotal role 
of the Hh signaling pathway in epi-
dermal carcinogenesis began with the 
identification of the Ptch1 gene as the 
site of mutations underlying the rare 
autosomal dominant heritable basal-
cell nevus syndrome (Gorlin’s syn-
drome), one cardinal feature of which 
is a high susceptibility to the devel-
opment of BCCs (Aszterbaum et al., 
1998; Hahn et al., 1996). The BCCs in 
these subjects frequently lose function 
of the inherited wild-type Ptch1 allele, 
leaving the tumor cells functionally 
null of Ptch1. It has subsequently 
become clear that essentially all BCCs, 
whether arising in patients with basal 
cell nevus syndrome or sporadically, 
have mutations in Ptch1 or other alter-
ations in Hh signaling (Aszterbaum 
et al., 1999). This appreciation has 
resulted in the development of the 
Ptch1+/– (Gorlin) mouse as the first 
practical model of murine BCC (Regl 
et al., 2004a). Treatment of these mice 
(unlike treatment of Ptch1 wild-type 
mice) with UVR or ionizing radiation 
produces BCC as well as SCC (Regl 
et al., 2004a). Ptch1 is the membrane 
receptor for sonic hedgehog (Shh). 
In the absence of Shh, Ptch1 inhib-
its the function of another membrane 
protein, smoothened (Smoh). Shh 
reverses this inhibition, freeing Smoh 
to enable the activation of a family of 
transcription factors, Gli1 and Gli2. 
Gli1 and -2 overexpression in keratin-
ocytes can increase the expression of 
each other as well as Ptch1, the anti-
apoptotic factor bcl2, cyclins D1 and 
D2, E2F1, and cdc45 (all of which 
promote proliferation) while suppress-
ing genes associated with keratinocyte 
differentiation such as K1, K10, invo-
lucrin, loricrin and VDR (Grachtchouk 
et al., 2000; Nilsson et al., 2000; Regl 
et al., 2002, 2004a,b). Mice overex-
pressing Gli1, Gli2, or Shh in their 
basal keratinocytes (Grachtchouk et 
al., 2000; Nilsson et al., 2000; Oro et 
al., 1997) or grafted with human kera-
tinocytes overexpressing Shh (Fan et 
al., 1997) develop BCC-like lesions. 
Furthermore, BCCs demonstrate over-
expression of Ptch1, Smoh, Gli1, and 
Gli2 (Bonifas et al., 2001; Tojo et al., 
1999). A number of the Hh pathway 
components, including both Gli1 and 
-2, have consensus vitamin D response 
elements in their promoters (Palmer 
et al., 2008; Wang et al., 2005). We 
(A. Teichert, J. Welsh, and D. Bikle, 
unpublished data) reported that the 
epidermis and epidermal portion (utri-
cles) of the hair follicles of VDR null 
animals overexpress elements of the 
Hh signaling pathway, suggesting that 
one of the causes of the increased sus-
ceptibility of the epidermis to malig-
nant transformation is a loss of VDR 
regulation of Hh signaling.
The wnt signaling pathway may 
also be involved. In a recent paper, 
Palmer et al. (2008) reported the inter-
action of VDR and wnt signaling in the 
regulation of hair follicle differentiation 
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interaction with NER remains unclear. 
However, when Moll et al. (2007) per-
formed microarray studies of kerati-
nocytes treated with 1,25(OH)2D3 for 
24 hours, they observed an upregula-
tion of two genes important for DDR: 
XPC and DDB2/XPE. Accordingly, 
1,25(OH)2D3 and VDR may be protec-
tive against UVR-induced epidermal 
tumor formation by stimulating DDR 
as well as by suppressing Hh and wnt 
signaling.
Ellison et al. (2008) make the impor-
tant point that VDR serves as a tumor 
suppressor not only for chemically 
induced epidermal carcinogenesis but 
also for the more physiologically rel-
evant UVR-induced epidermal carcino-
genesis. Although these authors have 
convincingly demonstrated that the 
former is a 1,25(OH)2D3-independent 
action of VDR, this conclusion cannot 
yet be extended to UVR-induced car-
cinogenesis. Earlier studies indicated 
several mechanisms by which VDR, 
with or without its ligand 1,25(OH)2D3, 
might be protective. These mechanisms 
include altered Hh and wnt signal-
ing and increased DDR. Future inves-
tigations are required to determine 
which, if any, of these mechanisms are 
involved and the degree to which VDR 
acts through these mechanisms in a 
1,25(OH)2D3-dependent or -indepen-
dent manner. However, this publication 
establishes an important fact: the skin 
has evolved a way of protecting itself 
from the deleterious actions of UVR 
using a key component of the pathway 
promoted by UVR, namely, the VDR.
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Oxidative Stress and “Senescent” 
Fibroblasts in Non-Healing Wounds 
as Potential Therapeutic Targets
Richard A.F. Clark1
In chronic wounds, fibroblast dysfunctions, such as increased apoptosis, 
premature senescence, senescence-like phenotype, or poor growth response in 
the absence of senescence markers, have been reported.   Some of these differ-
ential dysfunctions may be secondary to differences in patient age or sex, ulcer 
size or duration, edge versus base sampling, or culture technique.  Nevertheless, 
the entire spectrum of fibroblast dysfunction may exist and be secondary to, or 
a response to, different amounts of oxidative stress. 
Journal of Investigative Dermatology (2008), 128, 2361–2364. doi:10.1038/jid.2008.257
In their article entitled “Fibroblast 
dysfunction is a key factor in the non- 
healing of chronic venous leg ulcers,” 
Wall et al. (2008, this issue) demon-
strate that a telomere-independent 
fibroblast abnormality occurs in chronic 
venous leg ulcers and posit that oxida-
tive stress underlies this dysfunctional 
behavior. Although it is dysfunctional, 
the authors have clearly emphasized 
both here and in a previous publication 
(Stephens et al., 2003) that the chronic 
wound fibroblast phenotype observed 
by them does not represent the replica-
tive senescence-like phenotype as has 
been reported for chronic wound fibro-
blasts by a number of other investiga-
tors (Agren et al., 1999; Mendez et al., 
1998; Stanley and Osler, 2001; Stanley 
et al., 1997; Vande Berg et al., 1998, 
2005). However, Stephens’s group iso-
lated their chronic wound fibroblasts 
from biopsy specimens that come from 
the ulcer base while all other groups 
harvested chronic wound fibroblasts 
from the ulcer edge. Given the hetero-
geneity in growth response and other 
functions among human fibroblasts 
derived from either papillary or reticu-
lar dermis (Harper and Grove, 1979; 
Sorrell et al., 2008; Sorrell and Caplan, 
2004), it is not surprising that Stephens’s 
group has identified a different chronic 
wound fibroblast phenotype from the 
ulcer bed than the previously described 
fibroblast phenotype from the ulcer 
margin.
Nevertheless, the fibroblast pheno-
types reported by all groups of investi-
gators are consistent with the variety of 
functional changes that can be induced 
by oxidative stress on fibroblasts 
(Wlaschek and Scharffetter-Kochanek, 
2005). As pointed out by Wall et al. 
(2008), the oxidative effects on fibro-
blast phenotype and function depend 
on the level and length of exposure 
to reactive oxygen species (ROS). 
Low-level, chronic exposure to ROS 
accelerates telomere shortening (von 
Zglinicki, 2002), whereas high levels 
of ROS induce telomere-independent 
premature senescence (Song et al., 
2005). Another important aspect of the 
cell “senescence” response to oxida-
tive stress is cell age; aged human der-
mal fibroblasts demonstrate increased 
entrance into a senescent state com-
pared with their younger counter-
parts when exposed to oxidative stress 
(Gurjala et al., 2005). Furthermore, 
depending on the physiologic state of 
the cell, oxidative stress can induce 
apoptosis rather than senescence (Chen 
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